| Identification | More | [Name]
FMOC-D-2-Fluorophe | [CAS]
198545-46-9 | [Synonyms]
D-2-FLUOROPHENYLALANINE, FMOC PROTECTED
Fluorenylmethoxycarbonyl-D-2-fluorophenylalanine
FMOC-2-FLUORO-D-PHE
FMOC-2-FLUORO-D-PHENYLALANINE
FMOC-D-2-FLUOROPHE
FMOC-D-2-FLUOROPHENYLALANINE
FMOC-D-PHE(2-F)-OH
FMOC-D-PHE(O-F)-OH
FMOC-O-FLUORO-D-PHE-OH
FMOC-(R)-2-AMINO-3-(2'-FLUOROPHENYL)PROPANOIC ACID
N-(9-FLUORENYLMETHOXYCARBONYL)-2-FLUOROPHENYL-D-ALANINE
N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-D-2-FLUOROPHENYLALANINE
(R)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(2-FLUORO-PHENYL)-PROPIONIC ACID
RARECHEM BK PT 0024
(R)-N-FMOC-2-FLUOROPHENYLALANINE
(R)-N-FMOC-2-FLUOROPHENYLALANINE 98%
N-Fluorenemethoxycarbonyl-D-2-Fluoro Phenylalanine
2-Fluoro-D-phenylalanine,N-FMOCprotected
(R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(2-fluorophenyl)propanoic acid
FMOC-D-2-FLUORO-PHE-OH | [Molecular Formula]
C24H20FNO4 | [MDL Number]
MFCD00672553 | [Molecular Weight]
405.42 | [MOL File]
198545-46-9.mol |
| Chemical Properties | Back Directory | [Appearance]
off-white to beige crystalline powder | [Melting point ]
145.3 °C | [alpha ]
44 º (c=1,DMF) | [Boiling point ]
620.3±55.0 °C(Predicted) | [density ]
1.2642 (estimate) | [storage temp. ]
2-8°C
| [form ]
Solid | [pka]
3.76±0.11(Predicted) | [color ]
White to off-white | [Major Application]
peptide synthesis | [InChI]
1S/C24H20FNO4/c25-21-12-6-1-7-15(21)13-22(23(27)28)26-24(29)30-14-20-18-10-4-2-8-16(18)17-9-3-5-11-19(17)20/h1-12,20,22H,13-14H2,(H,26,29)(H,27,28)/t22-/m1/s1 | [InChIKey]
ARHOAMSIDCQWEW-JOCHJYFZSA-N | [SMILES]
OC(=O)[C@@H](Cc1ccccc1F)NC(=O)OCC2c3ccccc3-c4ccccc24 | [CAS DataBase Reference]
198545-46-9(CAS DataBase Reference) |
| Safety Data | Back Directory | [Safety Statements ]
S24/25:Avoid contact with skin and eyes . | [WGK Germany ]
3
| [Hazard Note ]
Harmful | [HS Code ]
2922498590 | [Storage Class]
11 - Combustible Solids |
| Hazard Information | Back Directory | [Chemical Properties]
off-white to beige crystalline powder | [Uses]
peptide synthesis | [reaction suitability]
reaction type: Fmoc solid-phase peptide synthesis |
|
|